Baker Chad R Biogen Inc. Transaction History

Baker Chad R

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$220.06 - $304.07 $2.64 Million - $3.65 Million	-11,995 Closed	0 $0
Q1 2019 May 07, 2019	BUY	$216.71 - $338.96 $1.83 Million - $2.86 Million	8,445 Added 237.89%	11,995 $2.84 Million
Q1 2018 May 14, 2018	BUY	$260.13 - $367.91 $923,461 - $1.31 Million	3,550 New	3,550 $972,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Baker Chad R, based on Form 13F filings with the SEC.

Stay updated on Baker Chad R with notifications on news.